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Stress, the Brain and Behavior 
In a society run by deadlines, the clock, modern technology and numerous other demands and 
pressures, stress is an unavoidable part of everyday life. When an individual encounters an 
event that is mentally evaluated or ‘appraised’ as a difficult to cope with threat to well-being 
(e.g. (Folkman and Folkman, 1984)), the body initiates a stress response (e.g.(McEwen, 
2007)). A stress response will express itself in a physiological as well as cognitive-affective 
reaction (e.g.(Steptoe et al., 2007)). In the brain, there is a stress-system (hypothalamic-
pituitary-adrenal axis or HPA) that transfers the perceived stressful event into autonomic and 
neuroendocrine changes throughout the body that are needed for stress adaptation (see (Ursin 
and Olff, 1993, Akil and Morano, 1995) for a review). Briefly, the perception of stress first 
quickly initiates a sympathetic release of stress hormones (norepinephrine from nerve terminals 
and plasma epinephrine from the adrenal glands) into the blood stream. This increase in stress 
hormones will then leads to increases in heart rate, blood pressure and blood glucose levels that 
are all needed for immediate defense or stress adaptation (coping). Upon receiving such fast 
limbic and hormonal stress inputs, 
additional cell bodies in the brain and 
periphery glands are then stimulated 
to release cortisol (from the cortex of 
the adrenal glands) that, in turn, is 
needed to restore the internal balance 
of the highly activated nervous 
system via a variety of complex 
feedback actions in the brain (see for 
a full review (Markus, 2008).  
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If a stress response is caused by a brief exposure to danger, then this response is well designed 
to support us with the necessary energy to cope with the dangerous situation. For instance, if 
your blood pressure becomes 190/120 because you noticed a predator coming after you during 
your stay in Africa, then you are not suffering from a disease but you are just showing a 
normal response meant to save your life. The trouble begins when the body is exposed to 
stress responses for longer periods of time due to cognitive-emotional worrying (e.g. always 
trying to be someone else, thinking frustrating things or working under mental load, 
continuing bad relationships, committing yourself to things you’re not up to, and more) -
which is not uncommon in humans. Such a prolonged exposure to stress and its associated 
bodily responses will have long-lasting detrimental effects on brain structures and functions 
that may ultimately lead to a wide-range of different physiological, behavioral and/or 
psychiatric disorders (e.g. (McEwen and Wingfield, 2003, van Praag, 2004, Steckler et al., 
2005)). In this respect, stress is one of the most important leading causes of current 
psychopathological diseases burden throughout the world and is often associated with severe 
medical consequences and mortality. The most typical stress-related ‘diseases’ are mood-
related disorders such as depression and often related eating-, sleep-, and cognitive-attentional 
disorders. 
 
Stress-proneness; individual differences  
An important feature of both the physiological as well as the affective stress response is that it 
differs greatly in strength among different individuals as well as across different situations or 
tasks (e.g. (Boyce and Ellis, 2005, Kudielka et al., 2009)). Two individuals exposed to the 
same situation may differ substantially in the strength and duration of their stress responses. 
These inter-individual differences in stress reactivity are assumed to underlie the current 
existence of a broad variability in stress-illness and/or stress-psychopathology associations 
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(e.g.(Boyce and Ellis, 2005, Steckler et al., 2005, Ursin and Olff, 1993)). As illustrated in 
Figure 1, maladaptive physiological and affective stress reactivity places individuals at a 
heightened risk for the development of a variety of stress-related disorders, whereas 
appropriate stress reactivity may act as a resilience factor preventing the development of 
stress-related psychopathology (e.g. (Feder et al., 2009)).   
 
 
 
 
 
 
 
 
 
 
Since maladaptive physiological and affective stress responses are involved in a wide range of 
physiological and psychopathological processes, it is highly important to identify 
vulnerability factors that contribute to inter-individual differences in stress reactivity and 
consequent susceptibilities for the development of stress-related disorders (Bartolomucci, 
2005). Although there is as yet no complete understanding of the origins of inter-individual 
differences in physiological and affective stress reactivity, there is now wide 
acknowledgement that both genetic and cognitive-mental variables are involved (e.g.(Boyce 
and Ellis, 2005, Markus, 2008, Markus, 2013)). It is therefore my strong conviction that both 
biological and psychological factors and, in particular, their mutual interactions should be 
explored in order to reach a complete explanatory model for human (stress-related) diseases.  
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Bio-involvement: how genes influence brain resilience  
Genetic factors play an important role in shaping inter-individual differences in stress 
reactivity (e.g. (Mormede et al., 2002)). Genes are hypothesized to either protect against or 
increase the likelihood of inadequate physiological and affective stress responsiveness; 
causing stress resilience in some individuals and leading to psychopathology in others (e.g. 
(Feder et al., 2009, Belsky and Pluess, 2009, Leigh, 2009)). Genes are able to do this by 
producing (and controlling) the basic chemical signal-substances in the brain. These so called 
‘communication substances’ or neurotransmitters are the main electro-chemical signals by 
which the brain’s nerve cells communicate; by transferring signals from the one cell to the other 
cell and selectively altering (enhancing or inhibiting) neural activation. Given that stress 
reactivity is partly heritable (e.g. (Bartels et al., 2003)) and that the brain neurotransmitter 
serotonin (5-Hydroxytryptamine or 5-HT) has been most clearly and systematically 
demonstrated to be involved in stress and a range of stress-related behavioral-affective 
disorders (e.g. (Graeff et al., 1996, Linthorst, 2005, van Praag, 2004, Markus et al., 2008)); 
particular attention has been given to the role of genes that may make the brain’s serotonergic 
system vulnerable for stress reactivity and, hence, stress-illness.  
Briefly, functionality of the brain serotonin (5-HT) system partly depends on a gene that 
controls the serotonin transporter (5-HTT) (e.g.(Hariri and Holmes, 2006); which is a 
monoamine carrier protein that transfers serotonin back into the presynaptic neuron (and, 
thus, the base for 5-HT neural communication). In the ‘promoter’ region of this gene, there is 
a functional differentiation (or a ‘variable repeat sequence polymorphism’; abbreviated by 5-
HTTLPR) that results in a short (S) and a long (L) promotor sequence variant. The S-variant 
of this 5-HTTLPR genotype is less active than the L-variant, causing lower 5-HT transporter 
binding and mRNA expression (Heils et al., 1996, Lesch et al., 1996). Consequently; the S-
6 
 
allele 5-HTTLPR variant, that is present in >60% of the population, is commonly found to 
promote brain serotonin dysfunction/disruptions and, hence, to increase stress proneness and 
the risk of developing stress-related affective disorders like depression (e.g. (van Praag, 2004, 
Hariri and Holmes, 2006, Firk and Markus, 2009, Markus et al., 2008, Markus, 2008, Caspi et 
al., 2010, Karg et al., 2011, Markus and Capello, 2012, Roy et al., 2014)).  
 
People who carry one or two copies of the S-allele 5HTTLPR gene show stronger activation 
of the emotional-stress brain network when confronted with fearful and/or other emotionally 
negative events (e.g.(Munafo et al., 2008, Alexander et al., 2012, Firk et al., 2013, Thomason 
et al., 2010, Madsen et al., 2016, Fisher et al., 2015, Hariri and Holmes, 2006, Hariri et al., 
2005)) as well as increased behavioral, emotional and/or neuroendocrine stress responses 
(e.g.(Gotlib et al., 2008, Markus and Firk, 2009, Markus and De Raedt, 2011, Verschoor and 
Markus, 2011, Markus, 2013, Capello and Markus, 2014, Cerit et al., 2013, Way and Taylor, 
2010, Dougherty et al., 2010, Firk and Markus, 2009). 
 
Most interesting, and in line with the classic diathesis-stress model, ample recent studies and 
meta-analyses reveal that the s-allele 5-HTTLPR genotype particularly increases the risk for 
stress-related affective disorders and other related illnesses in the presence of stressful events 
(e.g.(Caspi et al., 2010, Caspi et al., 2003, Wankerl et al., 2010, Karg et al., 2011, Miller et 
7 
 
al., 2013, Markus, 2013)). A first source of compelling evidence for this apparent Gene x 
Environment (stress exposure) interaction on stress-related disorders came from a seminal 
study by Caspi and colleagues (Caspi et al., 2003). Specifically, in this prospective 
longitudinal study it was reported that individuals carrying the S-allele of the 5-HTTLPR gene 
responded more readily to stressful life events with depression (and suicide) symptoms than 
individuals with the L-genotype. Since then a series of other epidemiological studies was 
performed of which most were able to replicate Caspi’s initial findings (see for reviews; 
(Uher and McGuffin, 2008, Karg et al., 2011)). In addition, many experimental imaging as 
well as acute stress exposure studies confirmed the involvement of the S-allele 5-HTTLPR 
genotype in heightened stress responsiveness (e.g.(Alexander et al., 2012, Munafo et al., 
2008, Gotlib et al., 2008, Mueller et al., 2010, Markus and De Raedt, 2011, Way and Taylor, 
2010, Firk et al., 2013). 
 
In need for additional research 
Although a broad range of epidemiological and acute stress exposure studies have thus 
supported the notion that a gene (the S-allele 5-HTTLPR genotype) meaningfully promotes 
stress responsiveness and, hence, contributes to the risk of developing stress-related affective 
disorders; there still are studies that could only partly or not at all replicate this gene (5-
HTTLPR) x Stress exposure interactive effects on the development of affective disorders 
(Uher and McGuffin, 2008, Karg et al., 2011, Sharpley et al., 2014). Such inconsistencies in 
findings  make it more likely that genes are (just) contributing instead of determining factors 
in the emergence of stress-related complaints or diseases (Markus, 2013). Consequently 
besides genes, there must be additional factors causing the large inter-individual differences in 
stress reactivity and disease susceptibility. After all, not all carriers of the S-allele 5-HTTLPR 
suffer from affective and/or stress-related disorders. Obviously, as befits a true psychologist, 
8 
 
we cannot blame our genes only for becoming affected under stress; there should be a crucial 
role for the way we perceive and process stressful experiences and its emotional impact.  
Reaching a workable biopsychological model for the development of stress-related 
psychopathological illness is one of the most desirable goals of today’s biopsychological 
research. The current chair aims to further fulfill this need by focusing on two major research 
topics: 1) how genetic and cognitive stress-vulnerability may mutually promote stress-related 
psychopathology and 2) to discover how food may intervene in such genetic and stress-
vulnerability interactions. In addition, particularly relating to the latter topic, a third (sub) aim 
is to find ways of better informing the broader public about the facts and especially myths that 
exist about the influence of food on brain and behavior.  
 
Aim 1: Genes, stress and psychopathology: where does cognition come into play? 
As mentioned earlier, the inconsistencies in findings regarding gene, brain and stress 
interactions in the development of stress-related illnesses might well be explained by the 
relative lack of consideration for moderating cognitive-psychological factors.  According to 
the generally accepted cognitive vulnerability-transactional stress model of negative 
affectivity and/or depression (Folkman and Folkman, 1984), the harmfulness of a stressor is 
primarily determined by the meaning and importance that we assign to it. In fact, an event 
becomes especially stressful when 1) it is experienced as personally relevant and highly 
(emotionally) threatening (‘primary appraisal’) and 2) when we do not have (belief in) 
adequate abilities/resources to cope with the stressor (‘secondary appraisal’) (Roberts et al., 
1987, Folkman and Folkman, 1984, Gunthert et al., 1999).  
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One’s evaluation of how stressful a threatening event might become, depends largely on the 
possession of, and belief in, adequate coping strategies (self-efficacy). This ‘belief in self-
efficacy’ is rather strongly influenced by personality (trait) characteristics that already emerge 
early in life and are continuously changing during meaningful person-environmental 
interactions across the lifespan. In particular personality characteristics that expresses high 
emotional vulnerability traits (e.g. neuroticism, trait anxiety) are thought to be most strongly 
related to stress proneness (e.g.(van Praag, 2004, Markus et al., 1998, Watson and Clark, 
1984)). For instance, individuals with high trait neuroticism are more vulnerable to experience 
stress (Watson and Clark, 1984, van Praag, 2004, Markus, 2013), have low expectations for 
self-efficacy and/or possess less-adaptive coping strategies (Gunthert et al., 1999, Penley et 
al., 2002) and are most vulnerable to develop stress-related emotional-behavioral disorders 
(Roberts and Kendler, 1999, van Praag, 2004). So whether or not an event might become 
highly stressful and/or will promote the development of stress-related diseases depends on 
biological (e.g. s-allele gene) as well as cognitive-emotional (personality factors such as 
neuroticism) vulnerability factors.  
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Whereas both genetic and cognitive vulnerability factors could in isolation promote stress-
related disorders, it is my strong conviction that this risk becomes especially profound when 
carrying both vulnerability factors in combination. For instance, perceiving an event as 
threatening (by cognitive appraisal) will lead to an enhanced brain serotonin (5-HT) and stress-
arousal (HPA) response to provide psycho-physiological stress adaptation (e.g. fight and flight 
behavior) (e.g.(Dickerson and Kemeny, 2004, van Praag, 2004, Markus, 2008)). However, 
when experiencing continuous stress (e.g. as a function of trait neuroticism or negative-
ruminative thinking patterns) this causes long-lasting increases in stress activation (and stress 
hormones) that will ultimately change or ‘imbalance’ the biological system by reducing 5-HT 
sensitivity and HPA function; thereby further increasing the risk for developing stress-related 
psychopathology (van Praag, 2004, Maes et al., 1995, Markus et al., 2000, Jans et al., 2007, 
Zoccola and Dickerson, 2012, Markus et al., 1999, Markus et al., 1998). Especially in 
combination with a genetic (s-allele 5-HTTLPR) vulnerability factor, this type of process is 
expected to further exacerbate the negative effects of long-lasting stress experiences; because 
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this genotype already promotes maladaptive brain 5-HT sensitization (to compensate for the 
lower 5-HTT expression; (David et al., 2005, Markus and De Raedt, 2011, Jans et al., 2007) 
and HPA stress responsiveness (Karg et al., 2011, Miller et al., 2012). Based on these findings 
and suggestions, it is most likely that not genes or psychological factors alone, but especially 
the combined presence of cognitive as well as genetic vulnerability factors will most 
profoundly increase the risk for developing stress-related psychopathology.  
Surprisingly, most studies focusing on such gene–stress-affective disorder relationships have 
thus far measured stress by just counting the number of self-reported stressful life events 
without meaningful consideration of possible cognitive moderators that determine the 
emotional impact of such events. Only a few recent studies, including our own work, provide 
first indirect support for such cognitive vulnerabilities mediating the 5-HTTLPR genotype by 
life event effects on depression symptomatology. For example, in a recent study conducted in 
our lab S-allele 5-HTTLPR carriers exhibited vulnerability to depression exclusively when 
they also reported exposure to high impact events and had high neuroticism scores (Markus, 
2013).  
 
Until now I have mainly focused on the importance of the combined presence of genetic, 
personal and environmental vulnerability factors for the development of affective disorders 
like depression. But as we know, there are many more behaviors known to be affected by 
stress, such as, for example, our eating- or sleep behavior but also our levels of 
attention/cognitive performance. For instance, as concerns eating, people often crave high-
calorie foods when feeling stressed or facing difficult emotional problems in daily life, and 
this ‘emotional eating’ is thought to be one of the most important causes for weight gain and 
obesity (e.g.(Markus and Capello, 2012, Schepers and Markus, 2015, Mellbin and Vuille, 
1989a, Mellbin and Vuille, 1989b, Kivimaki et al., 2006). In spite of intensive research from 
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both neurobiological and cognitive disciplines, the cause of emotional (over-)eating has not 
yet been elucidated while overweight and obesity still form a major problem for society as 
their incidence is still growing. Some of our own first studies in this direction indeed suggest 
that especially the combination of genetic (5-HTTLPR) and cognitive stress-vulnerabilities 
might promote emotional eating patterns under stress (Markus and Capello, 2012, Markus et 
al., 2015, Schepers and Markus, 2015). Comparable interactive effects of genetic and 
cognitive vulnerabilities and stress have been proposed for stress-related sleep-complaints 
(Brummett et al., 2007, van Dalfsen and Markus, 2015) or for the severity of ADHD 
symptoms under stress (van der Meer et al., 2015, Morgan et al., 2016).  
 
To summarize; a first aim of the current chair is to further explore the singular and interactive 
effects of bio-genetic (5HTTLPR), cognitive (neuroticism/rumination) and environmental 
factors (frequency of harmful life events) vulnerability factors on the onset and course of 
stress-related illnesses.  
 
Aim 2: can food influence stress vulnerability?  
Another interest that I have since I did my first PhD work in this area is the potential role of 
food on the brain and stress-related dysfunction. As previously described; dysfunctional brain 
serotonin (5-HT) neurotransmitter synthesis and release is one of the important biological 
vulnerability factors for high stress-sensitivity and the likelihood of developing stress-related 
psychopathology. Thus, if we could manipulate/restore 5-HT functioning in the brain this 
would have great impact on brain function/dysfunction and related behaviors. Interestingly, the 
synthesis/production of 5-HT in the brain is solely dependent on the availability of its dietary 
amino acid precursor tryptophan (TRP) in the blood. Tryptophan is a so called ‘essential amino 
acid’; meaning that the body cannot produce it by itself and it thus needs to be obtained from 
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food (from dietary proteins). In other words; if we do not obtain TRP from food, brain 5-HT will 
rapidly fall below functional need and will ultimately lead to serious brain and behavioral 
dysfunction. Since brain 5-HT synthesis is solely controlled by the dietary supply of its 
precursor TRP, 5-HT function can be changed by manipulating the diet in such a way that 
there is more (or less) available TRP in the blood for uptake into the brain. A rise in plasma 
(and brain) TRP can be accomplished by increasing dietary intake of TRP and/or by 
increasing the amount of sugar/carbohydrates in food. Both factors are shown to lead to a rise 
in plasma TRP relative to the sum of other large neutral amino acids (LNAA’s) that compete 
with TRP for transport into the brain (Fernstrom, 1990, Wurtman et al., 2003, Markus, 2008). 
Sugar and carbohydrates do not contain TRP, but cause an increase in brain TRP (and thus 5-
HT) by evoking an insulin response that sends the LNAA’s (except for TRP) into peripheral 
tissue (via this route  increasing the plasma TRP/LNAA ratio).  
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Contrary, although containing low percentages of TRP, proteins are usually found to decline 
plasma TRP/LNAA ratio’s because they contribute proportionately more LNAA’s. Appealing 
exceptions were reported for milk-derived (alpha-lactalbumin) proteins that caused large 
increases in plasma TRP/LNAA and brain 5-HT due to their higher TRP concentrations 
(Markus et al., 2002, Markus et al., 2005, Markus et al., 2008, Markus et al., 2000, Orosco et 
al., 2004).   
This ‘plasma amino acid to brain dependence’ is the same route as by which the 5-HT system 
signals brain (hypothalamic) areas to promote sugar and/or carbohydrate intake when 5-HT 
levels are too low (Simansky, 1996, Leibowitz and Alexander, 1998). In fact, there is a 
reciprocal relationship between the intake of proteins and carbohydrates and brain 5-HT; the 
intake of carbohydrates may inhibit further carbohydrate consumption by increases in plasma 
TRP/LNAA and brain 5-HT function, whereas protein consumption normally has the opposite 
effect by lowering the plasma TRP/LNAA ratio (Wurtman, 1984, Wurtman and Wurtman, 
1984). All such dietary effects on plasma and brain TRP and 5-HT synthesis are well 
documented in animal and human studies (Wurtman et al., 2003, Fernstrom, 1990, Markus et 
al., 1998, Markus, 2008). 
 
Interest in the relationship between food, plasma TRP/LNAA and brain 5-HT synthesis on the 
one hand, and between 5-HT, stress and its effects on mood/affectivity on the other hand has 
led to the completion of a variety of dietary studies carried out during the last decades. Many 
of these studies from our own, but also studies from other labs, have reported positive effects 
of carbohydrate-rich and/or TRP containing/enhancing diets on mood and/or stress sensitivity 
(Spring et al., 1987, Rogers, 1995, Christensen, 1997, Bellisle et al., 1998, Markus, 2008, 
Markus et al., 2008, Wurtman, 2011, Markus et al., 2010, Markus et al., 2000, Markus et al., 
2002), and recent studies reveal that this is more frequently reported in persons possessing the 
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earlier discussed cognitive and/or genetic (s-allele 5-HTTLPR) stress-vulnerability factors 
(Markus et al., 1998, Markus et al., 1999, Markus, 2008, Markus and Firk, 2009, Markus and 
De Raedt, 2011, Cerit et al., 2013, Capello and Markus, 2014). The other way around, TRP 
depletion is found to have the opposite effect in these vulnerable subjects (Neumeister et al., 
2002, Neumeister et al., 2006, Firk and Markus, 2009).  
Based on these findings, it is an intriguing possibility that 5-HT enhancing dietary 
manipulations may particularly interfere with the likelihood of developing stress-related 
disorders in those that possess both genetic (5-HTTLPR) and cognitive stress vulnerability 
factors in combination. Such research has only been recently started and already reveal some 
support for beneficial effects of 5-HT enhancing foods on stress related behavior; including 
effects on emotional-eating (Markus et al., 2015, Schepers and Markus, 2015), stress-
responsiveness (Markus et al., 2012, Cerit et al., 2013, Capello and Markus, 2014) and sleep 
quality (van Dalfsen and Markus, 2015). The current chair aims to continue and intensify 
further research on this topic. 
 
Sub-Aim: Informing the community about food-brain-behavior relations 
Since food and/or changes in diet-constitution are, under particular circumstances, capable of 
influencing brain function and related behavior, there has been a growing scientific and 
societal interest in the way nutrients may impact performance and social-emotional well-
being. Besides the previous described effects of tryptophan-enhancing foods (carbs, TRP or 
certain TRP-rich milk-derived proteins), 
other examples can be given ranging 
from, for example; 1) the beneficial 
effects of polyunsaturated fatty acids 
(e.g. oils from fish, nuts like omega-3) 
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on mood, depression symptomatology and/or cognitive-attentional-processing, 2) the effects 
of anti-oxidative foods like fruit, vegetables and/or vitamins on cognitive performance, 
intellectual ability and intelligence, 3) influence of multivitamins and/or minerals (zinc, 
copper, magnesium) on aggressive behavior, to 4) the mental boosting effects of certain herbs 
and/or botanicals like Ginkgo biloba or St John’s–wort (Hypericum perforatum) on memory, 
intellectual capacity or depression.  
In particular the suggested positive effects of foods or nutritional supplements on brain and 
behaviour have been picked up by the food industry, and has led to the launching of a wide 
range of often expensive natural (extracted) products on the nutraceutical market, with the 
promise that they will boost healthy mental processes and/or will reduce psychopathological 
disorders or symptoms involving depression, ADHD and/or memory loss.  
Although some of these food-behaviour assumptions or claims may reflect sound 
(biochemical) theoretical mechanisms of actions that are described and/or supported by the 
scientific literature (e,g, involving anti-oxidation, brain energy, cell-structures and/or neuro-
communication), most are based on just one or few (often methodologically-limited) studies 
and are seldom supported by meta-analyses of findings from studies with randomized-
controlled-designs (RCT).  For the broader public, it is however often hard to distinguish 
between good and bad scientific research and practice, making it even harder to discern facts 
from myths. Moreover, media and press (and even biased scientists) may sometimes falsely 
interpret, or even misuse, scientific findings of which the general public/consumers are not 
aware. I will restrict myself by giving just two most illustrative examples to show how 
scientific data can easily be misinterpreted and cause strong, but scientifically unsupported, 
beliefs about the effects of food in the broader public. The first example will be about food 
(sugar) addiction and obesity, and the second about food and ADHD symptoms. 
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Myth example-1: Sugar is an addictive drug that causes a worldwide increase in obesity. 
 With the worldwide increasing prevalence of overweight and its severe health consequences, 
the concept of ‘food addiction’ has gained popularity; not only in the lay public but also 
among food researchers, and in nutrition practices. In most recent discussions about health-
threatening snacks or foods,  particularly the sugary foods get a lot of attention because of 
their (by some) assumed addictive potential. This assumption is however not based on 
scientific evidence from studies with humans but on results from a few animal studies 
showing that sucrose intake in mice or rats can cause short moments of sugar bingeing (even 
without affecting weight) and can stimulate brain dopaminergic pathways. Since dopamine is 
also increased by addictive drugs, like for instance cocaine, this led to the false conclusion by 
some researchers that sugar is addictive; a message that was copied and presented to the 
broader public by the media and press. This all led to the a situation in which now many 
people believe that obesity is more strongly caused by sugar than by other palatable energy-
dense foods due to its addictive properties. 
 
The fact that sugar intake enhances 
dopaminergic activity in rats does 
however not justify the conclusion that it is thereby addictive since the dopaminergic reward 
system is not only activated in response to addictive stimuli or substances. Instead, the brain’s 
dopaminergic reward circuit is stimulated in lots of pleasurable situations that are not 
addictive, like when we watch nice events, when we win a price, when we listen to nice music 
or are in love  (Benton, 2010, Benton and Young, 2016). Furthermore, food-initiated changes 
in the brain have been shown to strongly differ from the drug-related changes (Benton, 2010, 
Choo and Sievenpiper, 2015, Benton and Young, 2016, Ziauddeen and Fletcher, 2013b). 
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Finally, there is a wealth of evidence from reviews and meta-analyses (only evaluating well-
controlled dietary human studies) clearly showing that sugar does not contribute to weight-
gain more so than other sources of energy in the diet (e.g. (Hebebrand et al., 2014, Ziauddeen 
et al., 2013, Ziauddeen and Fletcher, 2013a, Markus et al., Submitted, Wittekind and Walton, 
2014). Instead, there is clear scientific consensus that “food addiction” (and its role in weight 
gain) might be better explained by “eating dependence”; emphasizing that problematic eating 
behavior and related weight gain is not caused by a specific food, but rather is the result of 
unique individual experiences with food and eating. Despite all this evidence, such messages 
or contra-evidence are however barely picked up by the press/media making it hard for the 
broader public to correctly inform themselves.  
 
Myth example 2: Food colorants, artificial sweeteners and sugar cause ADHD  
There is a strong societal belief that artificial sweeteners, sugar and/or food colorants might 
cause hyperactivity and/or attentional problems as seen in children with ADHD. Some 
scientists have investigated this by either removing artificial elements from the food 
(elimination diets) or by increasing the intake of certain nutrients (challenge tests). Actually, 
many of these studies refer to a very old (methodologically weak) study in which a diet 
without artificial sweet-flavors and colorants (the Feingold diet) was claimed to reduce 
ADHD symptoms in children (Feingold, 1975b, Feingold, 1975a). However, support for this 
was only found in a minority of studies that were all methodologically weak (few participants, 
not blinded and/or randomized, uncontrolled dietary manipulations, bad diagnostic 
classifications and psychometric qualities of outcome measures, etc), whereas meta-analyses 
or reviews including well-controlled RCT experiments could not find any significant effect of 
such dietary manipulations or show rather mixed results (Wolraich et al., 1995, Bateman et 
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al., 2004, Cruz and Bahna, 2006). Nevertheless, parents even today are misled by information 
in the media, press that their children get “hyperactive” after eating a lot of sugar, artificial 
sweeteners and/or food colorants; even though high quality studies clearly reveal that such 
increases in hyperactivity are more likely caused by the circumstances associated with candy 
intake (birthday parties, holidays) instead of the food constituent itself. 
 
 
A rather illustrative RCT 
study (just to pick one...) is 
the one in which a sufficient 
number of ‘believing’-parents (believing that sugar might increase ADHD-related behavior) 
were invited with their sons to participate in a controlled laboratory experiment. They were 
told that the aim of the study was to observe the level of hyperactive behavior of their children 
after consumption of ‘sugar’ compared to a placebo beverage (PLC). In fact, what the parents 
did not know, was that all children were given the PLC drink. So, one half of the parents 
believed that their children received sugar drink whereas this actually was placebo, while the 
other half were correctly informed that their children received the PLC drink (Hoover and 
Milich, 1994). Thirty minutes after all the children consumed the placebo drink, the parents 
and an expert-observer who was blind to the conditions observed the children’s behavior for 
signs of hyperactivity/impulsivity.  Results revealed that only the parents who believed that 
their children consumed sugar (while they actually did not) reported significantly 
more/stronger ADHD behavior than parents (or expert-observers) that knew that children 
received PLC. 
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Thus, again, even though there is clear scientific consensus that ADHD symptoms are not 
meaningfully promoted by particular foods, this apparently is not interesting enough to be 
noticed and/or correctly interpreted by the press/media and broader public. 
 The final (third) aim of the current chair is to inform the broader public about facts and myths 
that exist regarding the influence of foods and/or macronutrients on the brain and behavior. 
One important starting point might be to convince society/the broader public that the scientific 
truth is not likely found in one uncontrolled study or on the internet, but at least needs careful 
scientific evaluation of the s average findings of multiple and only well-conducted RCT 
studies (e.g. preferably by using 
meta-analyses).  
 
 
 
Today, new insights from neuropsychology and biological psychology lead to the 
development of exciting and promising new biopsychological models that will hopefully 
enable us to better understand the onset and course of stress-related illness and 
psychopathology. In addition, research findings from the emerging interdisciplinary field of 
Nutritional Neuroscience might even further elaborate such new insights and models and will 
hopefully lead to the development of new innovative research lines and/or treatment strategies 
for stress-related disorders. It is my strong wish that the current chair will contribute to this 
endeavor. 
Rob Markus, 16 September, 2016  
21 
 
References 
AKIL, H. A. & MORANO, M. I. 1995. Stress, New York, Raven Press. 
ALEXANDER, N., KLUCKEN, T., KOPPE, G., OSINSKY, R., WALTER, B., VAITL, D., 
SAMMER, G., STARK, R. & HENNIG, J. 2012. Interaction of the serotonin 
transporter-linked polymorphic region and environmental adversity: increased 
amygdala-hypothalamus connectivity as a potential mechanism linking neural and 
endocrine hyperreactivity. Biol Psychiatry, 72, 49-56. 
BARTELS, M., VAN DEN BERG, M., SLUYTER, F., BOOMSMA, D. I. & DE GEUS, E. J. 
2003. Heritability of cortisol levels: review and simultaneous analysis of twin studies. 
Psychoneuroendocrinology, 28, 121-37. 
BARTOLOMUCCI, A. 2005. Resource loss and stress-related disease: is there a link? Med 
Sci Monit, 11, RA147-154. 
BATEMAN, B., WARNER, J. O., HUTCHINSON, E., DEAN, T., ROWLANDSON, P., 
GANT, C., GRUNDY, J., FITZGERALD, C. & STEVENSON, J. 2004. The effects of 
a double blind, placebo controlled, artificial food colourings and benzoate preservative 
challenge on hyperactivity in a general population sample of preschool children. Arch 
Dis Child, 89, 506-11. 
BELLISLE, F., BLUNDELL, J. E., DYE, L., FANTINO, M., FERN, E., FLETCHER, R. J., 
LAMBERT, J., ROBERFROID, M., SPECTER, S., WESTENHOFER, J. & 
WESTERTERP-PLANTENGA, M. S. 1998. Functional food science and behaviour 
and psychological functions. Br J Nutr, 80 Suppl 1, S173-93. 
BELSKY, J. & PLUESS, M. 2009. Beyond diathesis stress: differential susceptibility to 
environmental influences. Psychol Bull, 135, 885-908. 
BENTON, D. 2010. The plausibility of sugar addiction and its role in obesity and eating 
disorders. Clin Nutr, 29, 288-303. 
BENTON, D. & YOUNG, H. A. 2016. A meta-analysis of the relationship between brain 
dopamine receptors and obesity: a matter of changes in behavior rather than food 
addiction? Int J Obes (Lond), 40 Suppl 1, S12-21. 
BOYCE, W. T. & ELLIS, B. J. 2005. Biological sensitivity to context: I. An evolutionary-
developmental theory of the origins and functions of stress reactivity. Dev 
Psychopathol, 17, 271-301. 
BRUMMETT, B. H., KRYSTAL, A. D., ASHLEY-KOCH, A., KUHN, C. M., ZUCHNER, 
S., SIEGLER, I. C., BAREFOOT, J. C., BALLARD, E. L., GWYTHER, L. P. & 
WILLIAMS, R. B. 2007. Sleep quality varies as a function of 5-HTTLPR genotype 
and stress. Psychosom Med, 69, 621-4. 
CAPELLO, A. E. & MARKUS, C. R. 2014. Effect of sub chronic tryptophan 
supplementation on stress-induced cortisol and appetite in subjects differing in 5-
HTTLPR genotype and trait neuroticism. Psychoneuroendocrinology, 45, 96-107. 
CASPI, A., HARIRI, A. R., HOLMES, A., UHER, R. & MOFFITT, T. E. 2010. Genetic 
sensitivity to the environment: the case of the serotonin transporter gene and its 
implications for studying complex diseases and traits. Am J Psychiatry, 167, 509-27. 
CASPI, A., SUGDEN, K., MOFFITT, T. E., TAYLOR, A., CRAIG, I. W., HARRINGTON, 
H., MCCLAY, J., MILL, J., MARTIN, J., BRAITHWAITE, A. & POULTON, R. 
2003. Influence of life stress on depression: moderation by a polymorphism in the 5-
HTT gene. Science, 301, 386-9. 
CERIT, H., JANS, L. A. & VAN DER DOES, W. 2013. The effect of tryptophan on the 
cortisol response to social stress is modulated by the 5-HTTLPR genotype. 
Psychoneuroendocrinology, 38, 201-8. 
22 
 
CHOO, V. L. & SIEVENPIPER, J. L. 2015. The ecologic validity of fructose feeding trials: 
supraphysiological feeding of fructose in human trials requires careful consideration 
when drawing conclusions on cardiometabolic risk. Front Nutr, 2, 12. 
CHRISTENSEN, L. 1997. The effect of carbohydrates on affect. Nutrition, 13, 503-14. 
CRUZ, N. V. & BAHNA, S. L. 2006. Do food or additives cause behavior disorders? Pediatr 
Ann, 35, 744-5, 748-54. 
DAVID, S. P., MURTHY, N. V., RABINER, E. A., MUNAFO, M. R., JOHNSTONE, E. C., 
JACOB, R., WALTON, R. T. & GRASBY, P. M. 2005. A functional genetic variation 
of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J 
Neurosci, 25, 2586-90. 
DICKERSON, S. S. & KEMENY, M. E. 2004. Acute stressors and cortisol responses: a 
theoretical integration and synthesis of laboratory research. Psychol Bull, 130, 355-91. 
DOUGHERTY, L. R., KLEIN, D. N., CONGDON, E., CANLI, T. & HAYDEN, E. P. 2010. 
Interaction between 5-HTTLPR and BDNF Val66Met polymorphisms on HPA axis 
reactivity in preschoolers. Biol Psychol, 83, 93-100. 
FEDER, A., NESTLER, E. J. & CHARNEY, D. S. 2009. Psychobiology and molecular 
genetics of resilience. Nat Rev Neurosci, 10, 446-57. 
FEINGOLD, B. F. 1975a. Food additives in clinical medicine. Int J Dermatol, 14, 112-4. 
FEINGOLD, B. F. 1975b. Hyperkinesis and learning disabilities linked to artificial food 
flavors and colors. Am J Nurs, 75, 797-803. 
FERNSTROM, J. D. 1990. Aromatic amino acids and monoamine synthesis in the central 
nervous system: influence of the diet. J Nutr Biochem, 1, 508-17. 
FIRK, C. & MARKUS, C. R. 2009. Differential effects of 5-HTTLPR genotypes on mood, 
memory, and attention bias following acute tryptophan depletion and stress exposure. 
Psychopharmacology (Berl), 203, 805-18. 
FIRK, C., SIEP, N. & MARKUS, C. R. 2013. Serotonin transporter genotype modulates 
cognitive reappraisal of negative emotions: a functional magnetic resonance imaging 
study. Soc Cogn Affect Neurosci, 8, 247-58. 
FISHER, P. M., GRADY, C. L., MADSEN, M. K., STROTHER, S. C. & KNUDSEN, G. M. 
2015. 5-HTTLPR differentially predicts brain network responses to emotional faces. 
Hum Brain Mapp, 36, 2842-51. 
FOLKMAN, R. S. & FOLKMAN, S. 1984. Stress, appraisal and coping, New York, NY, 
Springer Publishing Company Inc. 
GOTLIB, I. H., JOORMANN, J., MINOR, K. L. & HALLMAYER, J. 2008. HPA axis 
reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and 
depression. Biol Psychiatry, 63, 847-51. 
GRAEFF, F. G., GUIMARAES, F. S., DE ANDRADE, T. G. & DEAKIN, J. F. 1996. Role of 
5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav, 54, 129-41. 
GUNTHERT, K. C., COHEN, L. H. & ARMELI, S. 1999. The role of neuroticism in daily 
stress and coping. J Pers Soc Psychol, 77, 1087-100. 
HARIRI, A. R., DRABANT, E. M., MUNOZ, K. E., KOLACHANA, B. S., MATTAY, V. S., 
EGAN, M. F. & WEINBERGER, D. R. 2005. A susceptibility gene for affective 
disorders and the response of the human amygdala. Arch Gen Psychiatry, 62, 146-52. 
HARIRI, A. R. & HOLMES, A. 2006. Genetics of emotional regulation: the role of the 
serotonin transporter in neural function. Trends Cogn Sci, 10, 182-91. 
HEBEBRAND, J., ALBAYRAK, O., ADAN, R., ANTEL, J., DIEGUEZ, C., DE JONG, J., 
LENG, G., MENZIES, J., MERCER, J. G., MURPHY, M., VAN DER PLASSE, G. & 
DICKSON, S. L. 2014. "Eating addiction", rather than "food addiction", better 
captures addictive-like eating behavior. Neurosci Biobehav Rev, 47, 295-306. 
23 
 
HEILS, A., TEUFEL, A., PETRI, S., STOBER, G., RIEDERER, P., BENGEL, D. & LESCH, 
K. P. 1996. Allelic variation of human serotonin transporter gene expression. J 
Neurochem, 66, 2621-4. 
HOOVER, D. W. & MILICH, R. 1994. Effects of sugar ingestion expectancies on mother-
child interactions. J Abnorm Child Psychol, 22, 501-15. 
JANS, L. A., RIEDEL, W. J., MARKUS, C. R. & BLOKLAND, A. 2007. Serotonergic 
vulnerability and depression: assumptions, experimental evidence and implications. 
Mol Psychiatry, 12, 522-43. 
KARG, K., BURMEISTER, M., SHEDDEN, K. & SEN, S. 2011. The serotonin transporter 
promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: 
evidence of genetic moderation. Arch Gen Psychiatry, 68, 444-54. 
KIVIMAKI, M., HEAD, J., FERRIE, J. E., SHIPLEY, M. J., BRUNNER, E., VAHTERA, J. 
& MARMOT, M. G. 2006. Work stress, weight gain and weight loss: evidence for 
bidirectional effects of job strain on body mass index in the Whitehall II study. Int J 
Obes (Lond), 30, 982-7. 
KUDIELKA, B. M., HELLHAMMER, D. H. & WUST, S. 2009. Why do we respond so 
differently? Reviewing determinants of human salivary cortisol responses to 
challenge. Psychoneuroendocrinology, 34, 2-18. 
LEIBOWITZ, S. F. & ALEXANDER, J. T. 1998. Hypothalamic serotonin in control of eating 
behavior, meal size, and body weight. Biol Psychiatry, 44, 851-64. 
LEIGH, H. 2009. A proposal for a new multiaxial model of psychiatric diagnosis. A 
continuum-based patient model derived from evolutionary developmental gene-
environment interaction. Psychopathology, 42, 1-10. 
LESCH, K. P., BENGEL, D., HEILS, A., SABOL, S. Z., GREENBERG, B. D., PETRI, S., 
BENJAMIN, J., MULLER, C. R., HAMER, D. H. & MURPHY, D. L. 1996. 
Association of anxiety-related traits with a polymorphism in the serotonin transporter 
gene regulatory region. Science, 274, 1527-31. 
LINTHORST, A. C. 2005. Interactions between corticotropin-releasing hormone and 
serotonin: implications for the aetiology and treatment of anxiety disorders. Handb 
Exp Pharmacol, 181-204. 
MADSEN, M. K., MC MAHON, B., ANDERSEN, S. B., SIEBNER, H. R., KNUDSEN, G. 
M. & FISHER, P. M. 2016. Threat-related amygdala functional connectivity is 
associated with 5-HTTLPR genotype and neuroticism. Soc Cogn Affect Neurosci, 11, 
140-9. 
MAES, M., MELTZER, H. Y., D'HONDT, P., COSYNS, P. & BLOCKX, P. 1995. Effects of 
serotonin precursors on the negative feedback effects of glucocorticoids on 
hypothalamic-pituitary-adrenal axis function in depression. 
Psychoneuroendocrinology, 20, 149-67. 
MARKUS, C. R. 2008. Dietary amino acids and brain serotonin function; implications for 
stress-related affective changes. Neuromolecular Med, 10, 247-58. 
MARKUS, C. R. 2013. Interaction between the 5-HTTLPR genotype, impact of stressful life 
events, and trait neuroticism on depressive symptoms in healthy volunteers. Psychiatr 
Genet, 23, 108-16. 
MARKUS, C. R. & CAPELLO, A. E. 2012. Contribution of the 5-HTTLPR gene by 
neuroticism on weight gain in male and female participants. Psychiatr Genet, 22, 279-
85. 
MARKUS, C. R. & DE RAEDT, R. 2011. Differential effects of 5-HTTLPR genotypes on 
inhibition of negative emotional information following acute stress exposure and 
tryptophan challenge. Neuropsychopharmacology, 36, 819-26. 
24 
 
MARKUS, C. R. & FIRK, C. 2009. Differential effects of tri-allelic 5-HTTLPR 
polymorphisms in healthy subjects on mood and stress performance after tryptophan 
challenge. Neuropsychopharmacology, 34, 2667-74. 
MARKUS, C. R., FIRK, C., GERHARDT, C., KLOEK, J. & SMOLDERS, G. F. 2008. Effect 
of different tryptophan sources on amino acids availability to the brain and mood in 
healthy volunteers. Psychopharmacology (Berl), 201, 107-14. 
MARKUS, C. R., JONKMAN, L. M., CAPELLO, A., LEINDERS, S. & HUSCH, F. 2015. 
Sucrose preload reduces snacking after mild mental stress in healthy participants as a 
function of 5-hydroxytryptamine transporter gene promoter polymorphism. Stress, 18, 
149-59. 
MARKUS, C. R., JONKMAN, L. M., LAMMERS, J. H., DEUTZ, N. E., MESSER, M. H. & 
RIGTERING, N. 2005. Evening intake of alpha-lactalbumin increases plasma 
tryptophan availability and improves morning alertness and brain measures of 
attention. Am J Clin Nutr, 81, 1026-33. 
MARKUS, C. R., OLIVIER, B. & DE HAAN, E. H. 2002. Whey protein rich in alpha-
lactalbumin increases the ratio of plasma tryptophan to the sum of the other large 
neutral amino acids and improves cognitive performance in stress-vulnerable subjects. 
Am J Clin Nutr, 75, 1051-6. 
MARKUS, C. R., OLIVIER, B., PANHUYSEN, G. E., VAN DER GUGTEN, J., ALLES, M. 
S., TUITEN, A., WESTENBERG, H. G., FEKKES, D., KOPPESCHAAR, H. F. & 
DE HAAN, E. E. 2000. The bovine protein alpha-lactalbumin increases the plasma 
ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects 
raises brain serotonin activity, reduces cortisol concentration, and improves mood 
under stress. Am J Clin Nutr, 71, 1536-44. 
MARKUS, C. R., PANHUYSEN, G., JONKMAN, L. M. & BACHMAN, M. 1999. 
Carbohydrate intake improves cognitive performance of stress-prone individuals under 
controllable laboratory stress. Br J Nutr, 82, 457-67. 
MARKUS, C. R., PANHUYSEN, G., TUITEN, A., KOPPESCHAAR, H., FEKKES, D. & 
PETERS, M. L. 1998. Does carbohydrate-rich, protein-poor food prevent a 
deterioration of mood and cognitive performance of stress-prone subjects when 
subjected to a stressful task? Appetite, 31, 49-65. 
MARKUS, C. R., ROGERS, P. J., BROUNS, F. & SCHEPERS, R. Submitted. Eating 
dependence and weight gain; no human evidence for a "suggar-addiction"model of 
overweight. Submitted to Addiction. 
MARKUS, C. R., VERSCHOOR, E., FIRK, C., KLOEK, J. & GERHARDT, C. C. 2010. 
Effect of tryptophan-rich egg protein hydrolysate on brain tryptophan availability, 
stress and performance. Clin Nutr, 29, 610-6. 
MARKUS, C. R., VERSCHOOR, E. & SMEETS, T. 2012. Differential effect of the 5-HTT 
gene-linked polymorphic region on emotional eating during stress exposure following 
tryptophan challenge. J Nutr Biochem, 23, 410-6. 
MCEWEN, B. S. 2007. Physiology and neurobiology of stress and adaptation: central role of 
the brain. Physiol Rev, 87, 873-904. 
MCEWEN, B. S. & WINGFIELD, J. C. 2003. The concept of allostasis in biology and 
biomedicine. Horm Behav, 43, 2-15. 
MELLBIN, T. & VUILLE, J. C. 1989a. Further evidence of an association between 
psychosocial problems and increase in relative weight between 7 and 10 years of age. 
Acta Paediatr Scand, 78, 576-80. 
MELLBIN, T. & VUILLE, J. C. 1989b. Rapidly developing overweight in school children as 
an indicator of psychosocial stress. Acta Paediatr Scand, 78, 568-75. 
25 
 
MILLER, R., WANKERL, M., STALDER, T., KIRSCHBAUM, C. & ALEXANDER, N. 
2012. The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and 
cortisol stress reactivity: a meta-analysis. Mol Psychiatry. 
MILLER, R., WANKERL, M., STALDER, T., KIRSCHBAUM, C. & ALEXANDER, N. 
2013. The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and 
cortisol stress reactivity: a meta-analysis. Mol Psychiatry, 18, 1018-24. 
MORGAN, J. E., HAMMEN, C. & LEE, S. S. 2016. Parental Serotonin Transporter 
Polymorphism (5-HTTLPR) Moderates Associations of Stress and Child Behavior 
With Parenting Behavior. J Clin Child Adolesc Psychol, 1-12. 
MORMEDE, P., COURVOISIER, H., RAMOS, A., MARISSAL-ARVY, N., OUSOVA, O., 
DESAUTES, C., DUCLOS, M., CHAOULOFF, F. & MOISAN, M. P. 2002. 
Molecular genetic approaches to investigate individual variations in behavioral and 
neuroendocrine stress responses. Psychoneuroendocrinology, 27, 563-83. 
MUELLER, A., BROCKE, B., FRIES, E., LESCH, K. P. & KIRSCHBAUM, C. 2010. The 
role of the serotonin transporter polymorphism for the endocrine stress response in 
newborns. Psychoneuroendocrinology, 35, 289-96. 
MUNAFO, M. R., BROWN, S. M. & HARIRI, A. R. 2008. Serotonin transporter (5-
HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry, 63, 
852-7. 
NEUMEISTER, A., HU, X. Z., LUCKENBAUGH, D. A., SCHWARZ, M., NUGENT, A. C., 
BONNE, O., HERSCOVITCH, P., GOLDMAN, D., DREVETS, W. C. & 
CHARNEY, D. S. 2006. Differential effects of 5-HTTLPR genotypes on the 
behavioral and neural responses to tryptophan depletion in patients with major 
depression and controls. Arch Gen Psychiatry, 63, 978-86. 
NEUMEISTER, A., KONSTANTINIDIS, A., STASTNY, J., SCHWARZ, M. J., VITOUCH, 
O., WILLEIT, M., PRASCHAK-RIEDER, N., ZACH, J., DE ZWAAN, M., BONDY, 
B., ACKENHEIL, M. & KASPER, S. 2002. Association between serotonin 
transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to 
tryptophan depletion in healthy women with and without family history of depression. 
Arch Gen Psychiatry, 59, 613-20. 
OROSCO, M., ROUCH, C., BESLOT, F., FEURTE, S., REGNAULT, A. & DAUGE, V. 
2004. Alpha-lactalbumin-enriched diets enhance serotonin release and induce 
anxiolytic and rewarding effects in the rat. Behav Brain Res, 148, 1-10. 
PENLEY, J. A., TOMAKA, J. & WIEBE, J. S. 2002. The association of coping to physical 
and psychological health outcomes: a meta-analytic review. J Behav Med, 25, 551-
603. 
ROBERTS, J. G., BROWNE, G., STREINER, D., BYRNE, C., BROWN, B. & LOVE, B. 
1987. Analyses of coping responses and adjustment: stability of conclusions. Nurs 
Res, 36, 94-7. 
ROBERTS, S. B. & KENDLER, K. S. 1999. Neuroticism and self-esteem as indices of the 
vulnerability to major depression in women. Psychol Med, 29, 1101-9. 
ROGERS, P. J. 1995. Food, mood and appetite. Nutr Res Rev, 8, 243-69. 
ROY, M., TAPADIA, M. G., JOSHI, S. & KOCH, B. 2014. Molecular and genetic basis of 
depression. J Genet, 93, 879-92. 
SCHEPERS, R. & MARKUS, C. R. 2015. Gene x cognition interaction on stress-induced 
eating: effect of rumination. Psychoneuroendocrinology, 54, 41-53. 
SHARPLEY, C. F., PALANISAMY, S. K., GLYDE, N. S., DILLINGHAM, P. W. & 
AGNEW, L. L. 2014. An update on the interaction between the serotonin transporter 
promoter variant (5-HTTLPR), stress and depression, plus an exploration of non-
confirming findings. Behav Brain Res, 273, 89-105. 
26 
 
SIMANSKY, K. J. 1996. Serotonergic control of the organization of feeding and satiety. 
Behav Brain Res, 73, 37-42. 
SPRING, B., CHIODO, J. & BOWEN, D. J. 1987. Carbohydrates, tryptophan, and behavior: 
a methodological review. Psychol Bull, 102, 234-56. 
STECKLER, T., KALIN, N. H. & REUL, J. M. H. M. 2005. Handbook of stress and the 
brain, Netherlands, Elsevier. 
STEPTOE, A., HAMER, M. & CHIDA, Y. 2007. The effects of acute psychological stress on 
circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav 
Immun, 21, 901-12. 
THOMASON, M. E., HENRY, M. L., PAUL HAMILTON, J., JOORMANN, J., PINE, D. S., 
ERNST, M., GOLDMAN, D., MOGG, K., BRADLEY, B. P., BRITTON, J. C., 
LINDSTROM, K. M., MONK, C. S., SANKIN, L. S., LOURO, H. M. & GOTLIB, I. 
H. 2010. Neural and behavioral responses to threatening emotion faces in children as a 
function of the short allele of the serotonin transporter gene. Biol Psychol, 85, 38-44. 
UHER, R. & MCGUFFIN, P. 2008. The moderation by the serotonin transporter gene of 
environmental adversity in the aetiology of mental illness: review and methodological 
analysis. Mol Psychiatry, 13, 131-46. 
URSIN, H. & OLFF, M. 1993. Psychobiology of coping and defence strategies. 
Neuropsychobiology, 28, 66-71. 
VAN DALFSEN, J. H. & MARKUS, C. R. 2015. Interaction between 5-HTTLPR genotype 
and cognitive stress vulnerability on sleep quality: effects of sub-chronic tryptophan 
administration. Int J Neuropsychopharmacol, 18. 
VAN DER MEER, D., HOEKSTRA, P. J., ZWIERS, M., MENNES, M., SCHWEREN, L. J., 
FRANKE, B., HESLENFELD, D. J., OOSTERLAAN, J., FARAONE, S. V., 
BUITELAAR, J. K. & HARTMAN, C. A. 2015. Brain Correlates of the Interaction 
Between 5-HTTLPR and Psychosocial Stress Mediating Attention Deficit 
Hyperactivity Disorder Severity. Am J Psychiatry, 172, 768-75. 
VAN PRAAG, H. M. 2004. Can stress cause depression? Prog Neuropsychopharmacol Biol 
Psychiatry, 28, 891-907. 
VERSCHOOR, E. & MARKUS, C. R. 2011. Affective and neuroendocrine stress reactivity to 
an academic examination: influence of the 5-HTTLPR genotype and trait neuroticism. 
Biol Psychol, 87, 439-49. 
WANKERL, M., ZYRIAX, B. C., BONDY, B., HINKELMANN, K., WINDLER, E. & 
OTTE, C. 2010. Serotonin transporter gene-linked polymorphic region (5-HTTLPR) 
and diurnal cortisol: A sex by genotype interaction. Biol Psychol, 85, 344-6. 
WATSON, D. & CLARK, L. A. 1984. Negative affectivity: the disposition to experience 
aversive emotional states. Psychol Bull, 96, 465-90. 
WAY, B. M. & TAYLOR, S. E. 2010. The serotonin transporter promoter polymorphism is 
associated with cortisol response to psychosocial stress. Biol Psychiatry, 67, 487-92. 
WITTEKIND, A. & WALTON, J. 2014. Worldwide trends in dietary sugars intake. Nutr Res 
Rev, 27, 330-45. 
WOLRAICH, M. L., WILSON, D. B. & WHITE, J. W. 1995. The effect of sugar on behavior 
or cognition in children. A meta-analysis. JAMA, 274, 1617-21. 
WURTMAN, R. J. 1984. Effects of foods and nutrients on brain neurotransmitters. Curr 
Concepts Nutr, 13, 103-12. 
WURTMAN, R. J. 2011. Non-nutritional uses of nutrients. Eur J Pharmacol, 668 Suppl 1, 
S10-5. 
WURTMAN, R. J. & WURTMAN, J. J. 1984. Nutrients, neurotransmitter synthesis, and the 
control of food intake. Res Publ Assoc Res Nerv Ment Dis, 62, 77-86. 
27 
 
WURTMAN, R. J., WURTMAN, J. J., REGAN, M. M., MCDERMOTT, J. M., TSAY, R. H. 
& BREU, J. J. 2003. Effects of normal meals rich in carbohydrates or proteins on 
plasma tryptophan and tyrosine ratios. Am J Clin Nutr, 77, 128-32. 
ZIAUDDEEN, H., CHAMBERLAIN, S. R., NATHAN, P. J., KOCH, A., MALTBY, K., 
BUSH, M., TAO, W. X., NAPOLITANO, A., SKEGGS, A. L., BROOKE, A. C., 
CHEKE, L., CLAYTON, N. S., SADAF FAROOQI, I., O'RAHILLY, S., 
WATERWORTH, D., SONG, K., HOSKING, L., RICHARDS, D. B., FLETCHER, 
P. C. & BULLMORE, E. T. 2013. Effects of the mu-opioid receptor antagonist 
GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism 
study in binge-eating obese subjects. Mol Psychiatry, 18, 1287-93. 
ZIAUDDEEN, H. & FLETCHER, P. C. 2013a. Central nervous system biomarkers for 
antiobesity drug development. Drug Discov Today, 18, 1282-91. 
ZIAUDDEEN, H. & FLETCHER, P. C. 2013b. Is food addiction a valid and useful concept? 
Obes Rev, 14, 19-28. 
ZOCCOLA, P. M. & DICKERSON, S. S. 2012. Assessing the relationship between 
rumination and cortisol: a review. J Psychosom Res, 73, 1-9. 
 
 

CBS 11884  Design & Print: Canon Business Services, M
aastricht
